About this trial
This study aims to evaluate the effects of interactive robot-based games on cognitive function, neuropsychiatric symptoms, and quality of life in patients with mild cognitive impairment and dementia. The investigators plan to recruit 80 participants and randomly assign them to a control group or an experimental group; the experimental group will participate in robot games for 12 weeks, while the control group will receive routine care. Data will be collected via questionnaires to investigate whether robot games can improve cognitive function, neuropsychiatric symptoms, and quality of life in patients with mild cognitive impairment and dementia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 50 years or older
Diagnosed by a physician with Mild Cognitive Impairment, mild, or moderate dementia
Able to communicate in Mandarin or Taiwanese
Willing to participate and provides informed consent signed by the participant or their family member/legal representative
Disqualifiers
Individuals who experience fear or aversion toward interactive robots or related equipment
Individuals with severe hearing or visual impairments that affect participation in activities
Individuals unable to complete the entire intervention due to unstable physical or mental conditions
Individuals deemed unsuitable for this study by physician assessment
Trial design
Parallel
Treatments tested in this trial
interactive robot game
Other interventionThe experimental group will engage in robot games for 12 weeks, twice weekly, about 20 minutes per session
Treatment groups
Trial outcomes
Primary outcomes
Montreal Cognitive Assessment(MoCA)
MoCA is one of the primary assessment indicators that investigators expect to see improved after interactive robot game interventions. The MoCA assessment covers multiple cognitive domains including attention and concentration, executive function, memory, language ability, visuospatial skills, abstract thinking, calculation ability, and orientation. The full score is 30 points, with higher scores indicating better cognitive function.
Neuropsychiatric Inventory Questionnaire(NPI-Q)
NPI-Q is one of the primary evaluation indicators investigators expect to improve after interactive robot game intervention. NPI-Q includes 12 items: delusions, hallucinations, agitation, depression, anxiety, abnormal motor behavior, sleep and nighttime behavior disorders, etc. Each item is scored for severity on a scale of 1-3 points, with higher scores indicating greater severity, and for caregiver distress on a scale of 0-5 points, with higher scores indicating greater distress. The total score is calculated by multiplying the severity and distress scores, with higher scores representing more severe symptoms.
Secondary outcomes
Quality of Life in Alzheimer's Disease(QoL-AD)
Quality of life is one of the secondary outcome measures that investigators expect to improve after an interactive robot game intervention. The QoL-AD scale is rated by the person with dementia and their caregiver on a four-point scale (poor, fair, good, very good) for each item, with total scores ranging from 13 to 52 points, where higher scores indicate better quality of life.
Geriatric Depression Scale 15(GDS-15)
The Geriatric Depression Scale-15 (GDS-15) is one of the secondary evaluation indicators that investigators hope will show improvement after an interactive robot game intervention. The GDS-15 is a self-administered assessment scale containing 15 items, with a total score ranging from 0 to 15 points, where higher scores indicate a greater tendency toward depression.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: